SOADOR
AKBA icon

State of Alaska Department of Revenue’s Akebia Therapeutics AKBA Stock Holding History

State of Alaska Department of Revenue’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Buy
246,078
+100,000
+68% +$119K ﹤0.01% 1588
2026
Q1 		$202K Hold
146,078
– – ﹤0.01% 1642
2025
Q4 		$235K Buy
146,078
+130,453
+835% +$273K ﹤0.01% 1635
2025
Q3 		$42K Buy
+15,625
New +$52K ﹤0.01% 1824

Other funds holding AKBA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State of Alaska Department of Revenue's AKBA Position: Q2 2026 in Review

State of Alaska Department of Revenue increased its Akebia Therapeutics (AKBA) stake by 68% in Q2 2026, buying an estimated $119K and bringing the position to 246,078 shares worth $279K. The position accounts for ﹤0.01% of the portfolio, ranked #1588.

State of Alaska Department of Revenue first reported a position in AKBA in Q3 2025 and has held it in 4 quarters since. 94 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

  • State of Alaska Department of Revenue held 246,078 shares of Akebia Therapeutics worth $279K as of Q2 2026.
  • State of Alaska Department of Revenue bought 100,000 Akebia Therapeutics shares in Q2 2026, an estimated $119K.
  • Akebia Therapeutics made up ﹤0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #1588 holding.
  • State of Alaska Department of Revenue first reported a position in Akebia Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 94 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.